Margaret Olinger

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Margaret Olinger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amylyx Pharmaceuticals, Inc. Chief Commercial Officer Common Stock 276,108 $5,178,792 $18.76 27 Dec 2023 Direct
Amylyx Pharmaceuticals, Inc. Chief Commercial Officer Stock Option (Right to Buy) 44,577 27 Dec 2023 Direct

Insider Reports Filed by Margaret Olinger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMLX Amylyx Pharmaceuticals, Inc. 27 Dec 2023 2 +$9,250 4 Chief Commercial Officer 29 Dec 2023, 16:07
AMLX Amylyx Pharmaceuticals, Inc. 12 Jul 2023 2 +$7,400 4 Chief Commercial Officer 14 Jul 2023, 16:20
AMLX Amylyx Pharmaceuticals, Inc. 22 May 2023 1 $0 4 Chief Commercial Officer 24 May 2023, 16:38
AMLX Amylyx Pharmaceuticals, Inc. 16 Mar 2023 2 $0 4 Chief Commercial Officer 20 Mar 2023, 20:27
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2023 2 +$87,225 4 Chief Commercial Officer 10 Jan 2023, 18:19
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 3 +$129,998 4 Chief Commercial Officer 10 Jan 2022, 19:30
AMLX Amylyx Pharmaceuticals, Inc. 06 Jan 2022 0 $0 3 Chief Commercial Officer 06 Jan 2022, 16:07